Christopher Hähner

Christopher Hähner has a diverse work experience spanning over two decades. Christopher is currently working as the Finance Director for Germany, Austria, and the Netherlands at Neuraxpharm, where they are responsible for leading all finance and accounting activities. Prior to this, they served as the Group CFO at Caesar & Loretz GmbH, where they played a key role in redesigning finance and accounting processes and implementing new ERP and finance systems. Christopher also had a successful tenure as the Group CFO at Heilpflanzenwohl AG, where they built and led various functions across the group. Christopher has also worked as a Managing Partner at Citova GmbH and as the Founder & GM of Urban Surfers Investment, which provided investment consultancy services in the digital health sector. Before that, they held multiple roles at Bayer AG, including CFO for Romania and Bulgaria, corporate finance for Europe, senior risk manager, and senior procurement manager. Christopher has a strong background in finance, accounting, operations, and project management, and they have demonstrated their ability to drive growth and deliver results throughout their career.

Christopher Hähner completed their education with an Abitur from Hardterberg Gymnasium. Christopher then went on to earn a Dipl. Bw. degree in Business Administration and Management from FOM University of Applied Sciences for Economics and Management. Later, they pursued a Master of Business Administration (MBA) with a specialization in International Business from the University of Bradford.